UNLABELLED: Chronic Obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality in the United States and internationally. The purpose of this study was to describe spirometry use in the diagnosis of COPD and to evaluate the management of COPD occurring in a primary care clinic. METHODS: Two hundred patients with a diagnosis of COPD attending a university-based family medicine clinic were randomly chosen for a retrospective medical record review. Pulmonary function testing, provision of smoking cessation advice and pharmacological management were compared to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease. RESULTS: Mean age was 65.4 years, 48% were male and 72% were Caucasian. Overall, 58.5% (n = 117) of patients had pulmonary function testing, with 60.7% acknowledged in the outpatient record; 55% (n = 110) were receiving medications in combinations that are recommended; and 40% of patients were receiving stage appropriate medications. 67.8% of current smokers were offered smoking cessation advice or treatment. CONCLUSIONS: Overall there was low use of recommended medication combinations and stage appropriate treatment, with better observance of diagnostic and risk factor reduction guidelines. In order to improve COPD care for patients, physicians need education about the recommended stepwise treatment options and office systems that promote integration of pulmonary function testing findings into care.
UNLABELLED: Chronic Obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality in the United States and internationally. The purpose of this study was to describe spirometry use in the diagnosis of COPD and to evaluate the management of COPD occurring in a primary care clinic. METHODS: Two hundred patients with a diagnosis of COPD attending a university-based family medicine clinic were randomly chosen for a retrospective medical record review. Pulmonary function testing, provision of smoking cessation advice and pharmacological management were compared to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease. RESULTS: Mean age was 65.4 years, 48% were male and 72% were Caucasian. Overall, 58.5% (n = 117) of patients had pulmonary function testing, with 60.7% acknowledged in the outpatient record; 55% (n = 110) were receiving medications in combinations that are recommended; and 40% of patients were receiving stage appropriate medications. 67.8% of current smokers were offered smoking cessation advice or treatment. CONCLUSIONS: Overall there was low use of recommended medication combinations and stage appropriate treatment, with better observance of diagnostic and risk factor reduction guidelines. In order to improve COPD care for patients, physicians need education about the recommended stepwise treatment options and office systems that promote integration of pulmonary function testing findings into care.
Authors: Xavier Perez; Juan P Wisnivesky; Linda Lurslurchachai; Lawrence C Kleinman; Ian M Kronish Journal: Respir Med Date: 2011-10-13 Impact factor: 3.415
Authors: Zaurbek Aisanov; Chunxue Bai; Otto Bauerle; Federico D Colodenco; Charles Feldman; Shu Hashimoto; Jose Jardim; Christopher K W Lai; Rafael Laniado-Laborin; Gilbert Nadeau; Abdullah Sayiner; Jae Jeong Shim; Ying Huang Tsai; Richard D Walters; Grant Waterer Journal: Int J Chron Obstruct Pulmon Dis Date: 2012-04-05
Authors: Nicolas Roche; Céline Pribil; Eric Van Ganse; Philippe Serrier; Bruno Housset; Déborah Poirier; Nathalie Texier; Stéphane Schück; Isabelle Boucot Journal: BMC Pulm Med Date: 2014-04-02 Impact factor: 3.317
Authors: Mohammed E Alsubaiei; Paul A Cafarella; Peter A Frith; R Doug McEvoy; Tanja W Effing Journal: Int J Chron Obstruct Pulmon Dis Date: 2015-11-04